Original document(5 pages)  中文版
    A Chinese medicine in the form of tablet for treating hemicrania, eyebrow bone pain and prosopantritis is proportionally prepared from dahurian angelica root, Chuan-xiong rhizome and green tea through thermal reflux in alcohol, filtering and concentrating for the first two, decocting and filtering for green tea, mixing, concentrating, adding beta-dextrin, stirring, vacuum drying, pulverizing, adding additive, granulating and tabletting.
Application Number
申请号		 200510033265 Application Date
申请日		 2005.02.23
Title 名称 Chinese medicinal composition for treating hemilateral headache and its preparation method
Publication Number
公开号		 1824036 Publication Date
公开日		 2006.08.30
Approval Pub. Date Granted Pub. Date
International Classification 分类号 A61K36/82,A61P25/06
Applicant(s) Name
申请人		 Guangzhou Guzhi Medicine Sci. & Tech. Dev. Co., Ltd.
Address 地址 510520
Inventor(s) Name 发明人 Wu Zhinan, Huang Nengzhang
Attorney & Agent 代理人 li yongqiang

  
Process for producing flavone compounds from skullcap (root)
Medicine for improving enterogastric function after radiation chemiotherapy
Chinese medicine composition for treating acne and its preparing method
Chinese medicine composition for treating baldness and its preparing method
Gout resisting Chinese medicine composition and its prepn process
Fleroxacin lactate dispersion tablet, and its prepn. method
Chinese medicinal tablet for treating gynecological inflammation and its preparation method
Chinese medicine composition for treating gout and preparing method thereof
Traditional Chinese medicine tablets or capsule for treating fracture and injury, and its preparing method
Medicine and food dual purpose product for preventing and treating vision syndrome due to television and computer display screen light injury
Google
Note:All patent data come from State Intellectual Property Office of the People's Republic of China. If there were discrepancies between here and the State Intellectual Property office, the later is more accurate. The patent data is only for public exchange and learning purposes. We are not responsible for the adverse consequences with unverified use of the data.